ONYX PHARMACEUTICALS INC Retained Earnings
ONYX PHARMACEUTICALS INC had Retained Earnings of -$737.91 million as of 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2013-08-09
- 2013-06-30: Retained Earnings (Accumulated Deficit) -$737.91M.
- 2013-03-31: Retained Earnings (Accumulated Deficit) -$684.74M.
- 2012-12-31: Retained Earnings (Accumulated Deficit) -$651.07M.
- 2012-09-30: Retained Earnings (Accumulated Deficit) -$608.15M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2013-06-30 | -$737.91M 10-Q · filed 2013-08-09 |
| 2013-03-31 | -$684.74M 10-Q · filed 2013-05-08 |
| 2012-12-31 | -$651.07M 10-Q · filed 2013-08-09 |
| 2012-09-30 | -$608.15M 10-Q · filed 2012-11-02 |
| 2012-06-30 | -$625.55M 10-Q · filed 2012-08-06 |
| 2012-03-31 | -$519.50M 10-Q · filed 2012-05-04 |
| 2011-12-31 | -$463.29M 10-K · filed 2013-02-28 |
| 2011-09-30 | -$679.96M 10-Q · filed 2011-11-03 |
| 2011-06-30 | -$643.10M 10-Q · filed 2011-08-09 |
| 2011-03-31 | -$588.56M 10-Q · filed 2011-05-10 |
| 2010-12-31 | -$539.40M 10-K · filed 2012-02-27 |
| 2010-09-30 | -$522.27M 10-Q · filed 2010-11-03 |
| 2010-06-30 | -$563.78M 10-Q · filed 2010-08-04 |
| 2009-12-31 | -$454.55M 10-K · filed 2011-02-23 |